Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kaye

Showing results (131-140 of 499) with videos related to

Pageof 50
Sort By:
BMJ (Clinical Research Ed.)|February 24, 2001
Pitfalls of pharmacoepidemiologyJ A Kaye, C Vasilakis-Scaramozza, S S Jick, et al.
BMJ (Clinical Research Ed.)|November 10, 2000
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisH Jick, J A Kaye, C Vasilakis-Scaramozza, et al.
British Journal of Cancer|May 3, 2002
Statin use, hyperlipidaemia, and the risk of breast cancerJ A Kaye, C R Meier, A M Walker, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinibK L Davis, J A Kaye, E T Masters, et al.
Journal of the American Geriatrics Society|March 1, 1992
The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomographyJ A Kaye, C DeCarli, J S Luxenberg, et al.
Obstetrics and Gynecology|December 24, 2008
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancerSusan S Jick, Katrina W Hagberg, James A Kaye, et al.
Neurology|July 15, 2009
Cognitive impairment risk: white matter hyperintensity progression mattersLisa C Silbert, Diane B Howieson, Hiroko Dodge, et al.
Archives of Internal Medicine|April 1, 1983
Cimetidine-induced interstitial nephritis with response to prednisone therapyW A Kaye, M A Passero, R J Solomon, et al.
Epilepsia|July 14, 1999
Seizure frequency and duration of epilepsy are not risk factors for postoperative seizure outcome in patients with hippocampal sclerosisC Kilpatrick, M Cook, Z Matkovic, et al.
Neurology|April 1, 1994
Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy agingB S Oken, S S Kishiyama, J A Kaye, et al.
Pageof 50

Showing results (131-140 of 499) with videos related to

Sort By:
Pageof 50
BMJ (Clinical Research Ed.)|February 24, 2001
Pitfalls of pharmacoepidemiologyJ A Kaye, C Vasilakis-Scaramozza, S S Jick, et al.
BMJ (Clinical Research Ed.)|November 10, 2000
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisH Jick, J A Kaye, C Vasilakis-Scaramozza, et al.
British Journal of Cancer|May 3, 2002
Statin use, hyperlipidaemia, and the risk of breast cancerJ A Kaye, C R Meier, A M Walker, et al.
Current Oncology (Toronto, Ont.)|March 7, 2018
Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinibK L Davis, J A Kaye, E T Masters, et al.
Journal of the American Geriatrics Society|March 1, 1992
The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomographyJ A Kaye, C DeCarli, J S Luxenberg, et al.
Obstetrics and Gynecology|December 24, 2008
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancerSusan S Jick, Katrina W Hagberg, James A Kaye, et al.
Neurology|July 15, 2009
Cognitive impairment risk: white matter hyperintensity progression mattersLisa C Silbert, Diane B Howieson, Hiroko Dodge, et al.
Archives of Internal Medicine|April 1, 1983
Cimetidine-induced interstitial nephritis with response to prednisone therapyW A Kaye, M A Passero, R J Solomon, et al.
Epilepsia|July 14, 1999
Seizure frequency and duration of epilepsy are not risk factors for postoperative seizure outcome in patients with hippocampal sclerosisC Kilpatrick, M Cook, Z Matkovic, et al.
Neurology|April 1, 1994
Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy agingB S Oken, S S Kishiyama, J A Kaye, et al.
Pageof 50